Why the study?
Does losartan limit aortic dilatation in patients >10 years old with Marfan Syndrome?
Does losartan limit aortic dilatation in patients >10 years old with Marfan Syndrome?
Losartan does not limit aortic dilatation in Marfan syndrome patients over 10 years old, supporting beta-blockers as standard first-line therapy.
Losartan does not limit aortic dilatation in Marfan syndrome despite BP reduction; challenges its routine use and reinforces beta-blockers as first-line.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Milleron et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: